EUVIMEDEUVIMED entdecken
Crossref

Association of Fibroblast Growth Factor 21 with Excessive Intrapancreatic Fat Deposition in Type 2 Diabetes Mellitus

Beste Ozturk, Mustafa Comoglu iD, Oguzhan Zengin, Esma Andac Uzdogan, Emre Buyukkaplan, Emra A Kalkan, Ihsan Ates

Experimental and Clinical Endocrinology & Diabetes · 03.07.2026

DOI: 10.1055/a-2899-6872 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, online erschienen am 03.07.2026. Verfasst von Beste Ozturk und 6 weiteren Autor:innen. Beteiligte Einrichtung: Ministry of Health Ankara Bilkent City Hospital, Department of Internal Medicine, Ankara, Turkey, Çankaya.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ObjectivesFibroblast growth factor 21 is a metabolic regulator involved in glucose and lipid homeostasis. However, its relationship with excessive intrapancreatic fat deposition in type 2 diabetes mellitus remains unclear. We aimed to evaluate the association between serum fibroblast growth factor 21 levels and excessive intrapancreatic fat deposition in patients with type 2 diabetes mellitus. MethodsThis prospective cross-sectional study included 101 participants who had previously undergone abdominal computed tomography. Group 1 consisted of patients with type 2 diabetes mellitus and excessive intrapancreatic fat deposition (n=31), Group 2 consisted of patients with type 2 diabetes mellitus without excessive intrapancreatic fat deposition (n=40), and Group 3 consisted of individuals without type 2 diabetes mellitus or excessive intrapancreatic fat deposition (n=30). Excessive intrapancreatic fat deposition was assessed on computed tomography by a blinded radiologist. Correlation, multivariable logistic regression, and receiver operating characteristic analyses were performed. ResultsFibroblast growth factor 21 levels were higher in Group 1 than in Groups 2 and 3 (82.32 pg/mL vs. 48.36 pg/mL vs 48.36 pg/mL, respectively; p

Autor:innen und Institutionen

  • Ministry of Health Ankara Bilkent City Hospital, Department of Internal Medicine, Ankara, Turkey, Çankaya.
  • Ministry of Health Ankara Bilkent City Hospital, Department of Biochemistry, Ankara, Turkey, Çankaya.
  • Ministry of Health Ankara Bilkent City Hospital, Department of Diagnostic Radiology, Ankara, Turkey, Çankaya.
  • Ministry of Health Ankara Bilkent City Hospital, Department of Internal Medicine, Turkey, Ankara.

ORCID-Profile: Mustafa Comoglu

Zitieren

APA

Ozturk, B., Comoglu, M., Zengin, O., Andac Uzdogan, E., Buyukkaplan, E., Kalkan, E. A., & Ates, I. (2026). Association of Fibroblast Growth Factor 21 with Excessive Intrapancreatic Fat Deposition in Type 2 Diabetes Mellitus. Experimental and Clinical Endocrinology & Diabetes. https://doi.org/10.1055/a-2899-6872

Vancouver

Ozturk B, Comoglu M, Zengin O, Andac Uzdogan E, Buyukkaplan E, Kalkan EA, et al. Association of Fibroblast Growth Factor 21 with Excessive Intrapancreatic Fat Deposition in Type 2 Diabetes Mellitus. Experimental and Clinical Endocrinology & Diabetes. 2026. doi:10.1055/a-2899-6872

BibTeX
@article{Ozturk2026,
  author = {Ozturk, Beste and Comoglu, Mustafa and Zengin, Oguzhan and Andac Uzdogan, Esma and Buyukkaplan, Emre and Kalkan, Emra A and Ates, Ihsan},
  title = {Association of Fibroblast Growth Factor 21 with Excessive Intrapancreatic Fat Deposition in Type 2 Diabetes Mellitus},
  journal = {Experimental and Clinical Endocrinology & Diabetes},
  year = {2026},
  doi = {10.1055/a-2899-6872}
}
Kostenlos starten →